203 research outputs found
Human Mesenchymal Stem Cells Self-Renew and Differentiate According to a Deterministic Hierarchy
BACKGROUND:Mesenchymal progenitor cells (MPCs) have been isolated from a variety of connective tissues, and are commonly called "mesenchymal stem cells" (MSCs). A stem cell is defined as having robust clonal self-renewal and multilineage differentiation potential. Accordingly, the term "MSC" has been criticised, as there is little data demonstrating self-renewal of definitive single-cell-derived (SCD) clonal populations from a mesenchymal cell source. METHODOLOGY/PRINCIPAL FINDINGS:Here we show that a tractable MPC population, human umbilical cord perivascular cells (HUCPVCs), was capable of multilineage differentiation in vitro and, more importantly, contributed to rapid connective tissue healing in vivo by producing bone, cartilage and fibrous stroma. Furthermore, HUCPVCs exhibit a high clonogenic frequency, allowing us to isolate definitive SCD parent and daughter clones from mixed gender suspensions as determined by Y-chromosome fluorescent in situ hybridization. CONCLUSIONS/SIGNIFICANCE:Analysis of the multilineage differentiation capacity of SCD parent clones and daughter clones enabled us to formulate a new hierarchical schema for MSC self-renewal and differentiation in which a self-renewing multipotent MSC gives rise to more restricted self-renewing progenitors that gradually lose differentiation potential until a state of complete restriction to the fibroblast is reached
Chitosan – poly(butylene succinate) scaffolds and human bone marrow stromal cells induce bone repair in a mouse calvaria model
Tissue engineering sustains the need of a three-dimensional (3D) scaffold to promote the
regeneration of tissues in volume. Usually, scaffolds are seeded with an adequate cell population,
allowing their growth and maturation upon implantation in vivo. Previous studies obtained by our
group evidenced significant growth patterns and osteogenic differentiation of human bone marrow
mesenchymal stem cells (hBMSCs) when seeded and cultured on melt-based porous chitosan
fibre mesh scaffolds (cell constructs). Therefore, it is crucial to test the in vivo performance of
these in vitro 3D cell constructs. In this study, chitosan-based scaffolds were seeded and cultured
in vitro with hBMSCs for 3 weeks under osteogenic stimulation conditions and analysed for cell
adhesion, proliferation and differentiation. Implantation of 2 weeks precultured cell constructs in
osteogenic culture conditions was performed into critical cranial size defects in nude mice. The
objective of this study was to verify the scaffold integration and new bone formation. At 8 weeks
of implantation, scaffolds were harvested and prepared for micro-computed tomography (ÎĽCT)
analysis. Retrieved implants showed good integration with the surrounding tissue and significant
bone formation, more evident for the scaffolds cultured and implanted with human cells. The results
of this work demonstrated that chitosan-based scaffolds, besides supporting in vitro proliferation
and osteogenic differentiation of hBMSCs, induced bone formation in vivo. Thus, their osteogenic
potential in orthotopic location in immunodeficient mice was validated, evidencing good prospects
for their use in bone tissue-engineering therapies.Ana Costa-Pinto was supported by Scholarship No. SFRH/24735/2005 from the Portuguese Research Council (Fundacao para a Ciencia e a Tecnologia; FCT). This work was partially supported by the EU Integrated Project GENOS-TEM ('Adult mesenchymal stem cells engineering for connective tissue disorders: from the bench to the bedside'; Grant No. LSHB-CT-2003-5033161) and the European Network of Excellence EXPERTISSUES Project (Grant No. NMP3-CT-2004-500283)
Signalling strategies for osteogenic differentiation of human umbilical cord mesenchymal stromal cells for 3D bone tissue engineering
Human umbilical cord mesenchymal stromal cells (hUCMSCs) have recently shown the capacity to differentiate into multiple cell lineages in all three embryonic germ layers. The osteogenic differentiation of hUCMSCs in monolayer culture has been reported, while the differentiation in three-dimensional biomaterials has not yet been reported for tissue-engineering applications. Thus, the aim of this study was to evaluate the feasibility of using hUCMSCs for bone tissue engineering. hUCMSCs were cultured in poly( L -lactic acid) (PLLA) scaffolds in osteogenic medium (OM) for 3 weeks, after which the scaffolds were exposed to several different media, including the OM, a mineralization medium (MM) and the MM with either 10 or 100 ng/ml insulin-like growth factor (IGF)-1. The osteogenic differentiation was confirmed by the up-regulation of Runx2 and OCN , calcium quantification and bone histology. Switching from the OM to the MM promoted collagen synthesis and calcium content per cell, while continuing in the OM retained more cells in the constructs and promoted higher osteogenic gene expression. The addition of IGF-1 into the MM had no effect on cell proliferation, differentiation and matrix synthesis. In conclusion, hUCMSCs show significant potential for bone tissue engineering and culturing in the OM throughout the entire period is beneficial for osteogenic differentiation of these cells. Copyright © 2009 John Wiley & Sons, Ltd.Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/63045/1/176_ftp.pd
Electrospun nanofibrous meshes cultured with Wharton’s Jelly Stem Cell: an alternative for cartilage regeneration, without the need of growth factors
Many efforts are being directed worldwide to the treatment of OA-focal lesions.
The majority of those efforts comprise either the refinement of surgical
techniques or combinations of biomaterials with various autologous cells.
Herein, we tested electrospun polycaprolactone (PCL) nanofibrous meshes for
cartilage tissue engineering. For that, articular chondrocytes (hACs) isolated
from human osteoarthritic joints and Whartonâ s Jelly Stem Cells (hWJSCs) are
cultured on electrospun nanofiber meshes, without adding external growth
factors. We observed higher glycosaminoglycans production and higher overexpression
of cartilage-related genes from hWJSCs cultured with basal medium,
when compared to hACs isolated from osteoarthritic joints. Moreover, the
presence of sulfated proteoglycans and collagen type II is observed on both
types of cell cultures. We believe that this effect is due to either the electrospun
nanofibers topography or the intrinsic chondrogenic differentiation potential of
hWJSCs. Therefore, we propose the electrospun nanofibrous scaffolds in
combination with hWJSCs as a viable alternative to the commercial membranes
used in autologous chondrogenic regeneration approaches.The authors thank the Portuguese Foundation for Science and
Technology for the Post-Doc grant of Marta Alves da Silva (SFRH/BPD/73322/2010, financed by POPH QREN Tipologia 4.1 – Advanced Formation, co-financed by Fundo Social Europeu and MEC
national funds). This work was supported by the project SPARTAN (PTDC/CTM-BIO/4388/2014) FCT/MEC with PIDDAC funds. It was also partly supported by the POLARIS (FP7-REGPOT-2012-2013-1) and the
Project “New methodologies for the isolation and control of stem cells
differentiation using advanced culturing conditions and/or nanomaterials”
(RL2 SCN NORTE-01-0124-FEDER-000018), co-financed by
North Portugal Regional Operational Programme (ON.2 – O Novo
Norte), under the National Strategic Reference Framework (NSRF),
through the European Regional Development Fund (ERDF).info:eu-repo/semantics/publishedVersio
Runt-Related Transcription Factor 2 Induction During Differentiation of Wharton's Jelly Mesenchymal Stem Cells to Osteoblasts Is Regulated by Jumonji AT-Rich Interactive Domain 1B Histone Demethylase
"In vitro" and multicolor phenotypic characterization of cell subpopulations identified in fresh human adipose tissue stromal vascular fraction and in the derived mesenchymal stem cells
Isolation, expansion and differentiation of mesenchymal stromal cells from rabbits' bone marrow
Mesenchymal stem cells secretome-induced axonal outgrowth is mediated by BDNF
Mesenchymal stem cells (MSCs) have been used for cell-based therapies in regenerative medicine, with increasing importance in central and peripheral nervous system repair. However, MSCs grafting present disadvantages, such as, a high number of cells required for transplantation and low survival rate when transplanted into the central nervous system (CNS). In line with this, MSCs secretome which present on its composition a wide range of molecules (neurotrophins, cytokines) and microvesicles, can be a solution to surpass these problems. However, the effect of MSCs secretome in axonal elongation is poorly understood. In this study, we demonstrate that application of MSCs secretome to both rat cortical and hippocampal neurons induces an increase in axonal length. In addition, we show that this growth effect is axonal intrinsic with no contribution from the cell body. To further understand which are the molecules required for secretome-induced axonal outgrowth effect, we depleted brain-derived neurotrophic factor (BDNF) from the secretome. Our results show that in the absence of BDNF, secretome-induced axonal elongation effect is lost and that axons present a reduced axonal growth rate. Altogether, our results demonstrate that MSCs secretome is able to promote axonal outgrowth in CNS neurons and this effect is mediated by BDNF.European Regional Development Fund (ERDF), through the Centro 2020 Regional Operational Programme under project CENTRO-01–0145-FEDER-000008:BrainHealth 2020, and through the COMPETE 2020 - Operational Programme for Competitiveness and Internationalisation and Portuguese national funds via FCT – Fundação para a Ciência e a Tecnologia, I.P., under projects PTDC/SAU-NEU/104100/2008, EXPL/NEU-NMC/0541/2012 and UID/NEU/04539/2013. This work was also funded by Marie Curie Actions - International reintegration grant #249288, 7th Framework programme, EU. Partially funded by Prémios Santa Casa Neurociências - Prize Melo e Castro for Spinal Cord Injury Research; Portuguese Foundation for Science and Technology (IF Development Grant to A.J.S.); NORTE-01-0145-FEDER-000013, supported by the Northern Portugal Regional Operational Programme; by FEDER funds, through the Competitiveness Factors Operational Programme (COMPETE), and by national funds, through the Foundation for Science and Technology (FCT), under the scope of the project POCI-01-0145-FEDER-007038. The authors would also like to acknowledge Prof. J.E. Davies from the Institute of Biomaterials and Biomedical Engineering at the University of Toronto, Canada, for kindly providing some of the HUCPVCs lots used in the present workinfo:eu-repo/semantics/publishedVersio
Edaravone Guards Dopamine Neurons in a Rotenone Model for Parkinson's Disease
3-methyl-1-phenyl-2-pyrazolin-5-one (edaravone), an effective free radical scavenger, provides neuroprotection in stroke models and patients. In this study, we investigated its neuroprotective effects in a chronic rotenone rat model for Parkinson's disease. Here we showed that a five-week treatment with edaravone abolished rotenone's activity to induce catalepsy, damage mitochondria and degenerate dopamine neurons in the midbrain of rotenone-treated rats. This abolishment was attributable at least partly to edaravone's inhibition of rotenone-induced reactive oxygen species production or apoptotic promoter Bax expression and its up-regulation of the vesicular monoamine transporter 2 (VMAT2) expression. Collectively, edaravone may provide novel clinical therapeutics for PD
Progenitor and stem cells for bone and cartilage regeneration
Research in regenerative medicine is developing at a significantly quick pace. Cell-based bone and
cartilage replacement is an evolving therapy aiming at the treatment of patients who suffer from
limb amputation, damaged tissues and various bone and cartilage-related disorders. Stem cells are
undifferentiated cells with the capability to regenerate into one or more committed cell lineages.
Stem cells isolated from multiple sources have been finding widespread use to advance the field of
tissue repair. The present review gives a comprehensive overview of the developments in stem cells
originating from different tissues and suggests future prospects for functional bone and cartilage
tissue regeneration.The European Network of Excellence EXPERTISSUES (Project No. NMP3-CT-2004-500283), under which this work was carried out, is acknowledged
- …